Pr ecis: These important findings suggest that COX-2 inhibitors should be investigated in breast cancer patients with brain metastases as a simple immediate strategy to prevent systemic recurrence. Pr ecis: By identifying a potential mediator of chromosomal instability in VHL-associated cancers, this study suggests a novel microRNA-based therapeutic strategy to target aneuploid cells in VHL-associated cancers.
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Pr ecis: Genetic ablation of adaptive immunity eliminates the development of tumors in a mouse model of gastric cancer driven by TGF-b hypomorphism, highlighting the critical contribution of inflammation to TGF-b-mediated tumorigenesis.
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ABOUT THE COVER
Aberrant expression of the T-box transcription factor brachyury in human carcinomas drives the phenomenon of epithelial-mesenchymal transition (EMT), a phenotypic modulation that facilitates tumor dissemination and resistance to conventional anti-neoplastic therapies. Hamilton and colleagues show that acquisition of a mesenchymal-like phenotype could also significantly reduce the susceptibility of cancer cells to lysis by both antigen-specific T cells and natural killer cells. This defect was observed even in the presence of a stable engagement between the immune effector cells and the tumor cells, as demonstrated by the effective polar actin polymerization observed at the interacting surface area. The phenomenon of immune resistance of mesenchymallike cells was correlated to their decreased levels of cell cycle kinase CDK1, a defect that could be countered by treatment with a specific inhibitor of WEE1. For details, see article by Hamilton and colleagues on page 2510. To request permission to re-use all or part of this article, contact the AACR Publications Department at
